The Knowledgeable Committee on vaccine administration beneath the chairmanship of NITI Aayog member Dr VK Paul will meet on Wednesday to think about the logistics and moral points of procurement and administration of COVID-19 vaccine, mentioned the Union Ministry of Well being and Household Welfare.
The Committee will have interaction with all of the stakeholders together with state governments and vaccine producers.
“The Knowledgeable Committee on Vaccine Administration beneath the chairmanship of Dr V Ok Paul, NITI Aayog will meet on 12th August to think about logistics & moral points of procurement & administration of #COVID19 vaccine,” the Ministry tweeted.
“The Committee will have interaction with all of the stakeholders together with State governments and vaccine producers,” it mentioned in one other tweet.
The Committee will have interaction with all of the stakeholders together with State governments and vaccine producers.@PMOIndia@drharshvardhan@AshwiniKChoubey@PIB_India@DDNewslive@airnewsalerts@COVIDNewsByMIB@CovidIndiaSeva@ICMRDELHI@NITIAayog@PTI_News@ANI
— Ministry of Well being (@MoHFW_INDIA) August 11, 2020
Based on the Indian Council of Medical Analysis (ICMR), three Indian COVID-19 vaccines are in numerous phases of medical testing at current.
“At this time second, we’ve three Indian vaccines which can be in numerous phases of medical testing. The two vaccines- Bharat Biotech vaccine and DNA vaccine of Zydus Cadila have accomplished part 1 and can start part 2 whereas third is Oxford vaccine,” mentioned prime ICMR scientist (Prof) Balram Bhargava.
“Oxford vaccine, being manufactured by Serum Institute of India (SII) acquired approval for part 2 and three medical trials, that are beginning inside every week at 17 websites,” he added.
India’s COVID-19 depend has crossed 22 lakh-mark together with 6,34,945 lively instances, 15,35,744 cured/discharged/migrated whereas the cumulative toll reached 44,386.
Nonetheless, the Well being Ministry has identified that the an infection is now concentrated in 10 States that contribute greater than 80 per cent of the brand new instances.